11/02/2026
🥳We made the switch! We now carry Credelio Quattro.🥳 We are excited to offer this product to your pet and all the benefits that come with it!
Credelio Quattro™/Credelio Quattro-CA1 covers more* parasite types than Simparica Trio and NexGard Plus, targeting 7 types of parasites,§ including the treatment and control of tapeworms** that these brands skip. Schedule your next vet visit with us to learn more about this parasite coverage. Don't delay–get $25 off of 6 doses and $65 off of 12 doses.
*Based on label comparison of the number of parasite types covered in a chewable that targets ticks.
§ Credelio Quattro protects dogs against ticks, fleas, heartworm disease, roundworms, hookworms, and tapeworms. Credelio Quattro-CA1 is conditionally approved for the treatment of New World screwworm larvae infestations in dogs pending a full demonstration of effectiveness.
** D.caninum, T. pisiformis, and E. granulosus
INDICATIONS: Credelio Quattro is indicated for the prevention of heartworm disease and the treatment and control of roundworm, hookworm, and tapeworm infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations and the treatment and control of tick infestations for 1 month in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Lyme disease infections as a direct result of killing black-legged ticks.
Credelio Quattro-CA1 is conditionally approved for the treatment of infestations caused by New World screwworm larvae in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.
IMPORTANT SAFETY INFORMATION: Lotilaner, an ingredient in Credelio Quattro/Credelio Quattro-CA1, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, incoordination, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro/Credelio Quattro-CA1 administration as it is not effective against adult heartworms. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Credelio Quattro-CA1 is conditionally approved by the FDA pending a full demonstration of effectiveness under application number 141-619. If you suspect that your dog is infested with NWS larvae, seek veterinary care immediately for treatment to include removal of larvae and appropriate wound care.
For complete safety information, please see the Credelio Quattro/Credelio Quattro-CA1
product label or ask your veterinarian.
Credelio Quattro, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2026 Elanco or its affiliates. PM-US-24-2087(5)
